From the Department of Endocrinology, l'Institut du Thorax, CHU de Nantes, Hôpital Nord.
CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes.
Clin Nucl Med. 2019 Sep;44(9):738-740. doi: 10.1097/RLU.0000000000002736.
We report the case of a 23-year-old man presenting a right hypersecreting pheochromocytoma, falsely negative on F-FDG PET/CT and on I-metaiodobenzylguanidine (I-MIBG) scintigraphy but strongly positive on F-FDOPA PET/CT. Functional imaging has a key role in diagnosis and prognosis of pheochromocytomas, but choosing the most relevant modality remains difficult. Despite its high specificity, I-MIBG has a limited sensitivity. F-FDG can be used, but it is an unspecific tracer, and F-FDG uptake in brown adipose tissue can hinder the analysis. However, F-FDOPA shows very high sensitivity and specificity in pheochromocytomas with fewer drug interferences than I-MIBG.
我们报告了一例 23 岁男性,表现为右嗜铬细胞瘤过度分泌,在 F-FDG PET/CT 和 I-间碘苄胍(I-MIBG)闪烁显像上均为假阴性,但在 F-FDOPA PET/CT 上呈强阳性。功能成像在嗜铬细胞瘤的诊断和预后中具有关键作用,但选择最相关的检查方式仍然具有挑战性。尽管 I-MIBG 具有很高的特异性,但它的灵敏度有限。可以使用 F-FDG,但它是一种非特异性示踪剂,棕色脂肪组织的 F-FDG 摄取会阻碍分析。然而,与 I-MIBG 相比,F-FDOPA 在嗜铬细胞瘤中具有更高的灵敏度和特异性,且药物干扰较少。